BASF raises offer above EUR 11 billion for Evonik stock

Published on 10/26/2026 at 10:14 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

The package implies EUR 24.00 per share, and Evonik stock costs EUR 21.11. That is 0.71 percent below the EUR 21.26 Xetra close on October 23, 2026.

Operating figures and next date

BASF's proposal exceeded EUR 11 billion on October 23, 2026.
Adjusted EBITDA reached EUR 630 million in the second quarter of 2026.
Evonik stock trades at EUR 21.11 at 10:08 a.m. CET at Lang & Schwarz on October 26, 2026, 0.71 percent below the Xetra close of October 23, 2026.
Evonik will publish its third-quarter 2026 report on November 3, 2026.

Extreme Makrofotografie transparenter Silikagelkugeln und Polymerpartikel auf schwarzem Hintergrund — Evonik Industries DE000EVNK013 zeigt eine extreme Makroaufnahme transluzenter Spezialsilika-Kugeln auf dunklem Hintergrund, Illustration mit AI erstellt.

Evonik (ISIN DE000EVNK013) trades at EUR 21.11 at Lang & Schwarz on October 26, 2026 at 10:08 a.m. CET, down 0.71 percent versus the Xetra close of October 23, 2026 at EUR 21.26. According to el7.ai on October 22, 2026, BASF had raised its proposal for Evonik above EUR 11 billion, with the reported package implying EUR 24.00 per share.

BASF offer changes the valuation

The reported proposal places a clear reference point above the market quotation, but it does not represent a completed transaction. At EUR 21.11, Evonik stock stands 13.69 percent below the reported EUR 24.00 per-share level.

Finanznachrichten reported on October 16, 2026 that Deutsche Bank Research kept a Hold rating and an EUR 18.00 price target. The analyst expected third-quarter operating earnings of EUR 640 million, slightly above consensus.

What does EUR 24.00 imply?

The offer level matters because Evonik's operating trend had improved before the takeover discussion. Yahoo Finance reported that adjusted EBITDA rose 24.00 percent year over year to EUR 630 million in the second quarter of 2026.

Three dated Evonik milestones

On July 15, 2026, adjusted EBITDA for the second quarter reached EUR 630 million, according to Yahoo Finance. On August 4, 2026, Evonik's investor-relations page described second-quarter performance and confirmed full-year adjusted EBITDA guidance of EUR 2.0 billion to EUR 2.2 billion.

On October 23, 2026, the reported BASF proposal moved above EUR 11 billion, according to el7.ai. That sequence leaves investors weighing a stronger operating base against the uncertainty of takeover talks.

Next report arrives November 3, 2026

Evonik's investor-relations page lists November 3, 2026 as the date for reporting on the third quarter of 2026. The release should provide the next company-specific test of the EUR 2.0 billion to EUR 2.2 billion full-year adjusted EBITDA guidance.

Stock stays below the offer level

The euro quotation remains below the reported proposal and above Deutsche Bank Research's EUR 18.00 target. Evonik was trading at EUR 21.11 at Lang & Schwarz on October 26, 2026 at 10:08 a.m. CET, 0.71 percent below the Xetra close of October 23, 2026 at EUR 21.26. The further course of trading is shown by the continuously updated real-time quote of Evonik stock.